Literature DB >> 10354091

Paronychia associated with antiretroviral therapy.

A Tosti1, B M Piraccini, A D'Antuono, S Marzaduri, V Bettoli.   

Abstract

We report six HIV patients who developed painful periungual inflammation of several nails during treatment with the antiretroviral drugs indinavir and lamivudine. The lesions appeared 2-12 months after starting treatment. The occurrence of paronychia in HIV patients has recently been reported in two groups of patients receiving either indinavir or lamivudine. Dermatologists should be aware of this recently reported and probably not uncommon side-effect of antiretroviral treatment in order to avoid an invasive approach to the nail lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354091     DOI: 10.1046/j.1365-2133.1999.02883.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  Indinavir-induced retinoid-like effects: incidence, clinical features and management.

Authors:  Jesús García-Silva; Manuel Almagro; Carmen Peña-Penabad; Eduardo Fonseca
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Nail Pyogenic Granuloma following Treatment with Blinatumomab.

Authors:  Dilshad Paurobally; Josette Andre; Bertrand Richert
Journal:  Skin Appendage Disord       Date:  2017-08-31

Review 3.  Drug-induced nail disorders: incidence, management and prognosis.

Authors:  B M Piraccini; A Tosti
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

Review 4.  Drug-induced skin, nail and hair disorders.

Authors:  Laurence Valeyrie-Allanore; Bruno Sassolas; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Optimal diagnosis and management of common nail disorders.

Authors:  Debra K Lee; Shari R Lipner
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 6.  Management of chronic paronychia.

Authors:  Vineet Relhan; Khushbu Goel; Shikha Bansal; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.